Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Autologous T cell therapy against CD19: Clinical trial data

January 25, 2016 8:00 AM UTC

Data from 41 evaluable patients with hematologic malignancies in clinical trials at NIH’s NCI showed that KTE-C19 led to an ORR of 78%, including 22 complete responses. In 27 patients with aggressive ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article